Cases 1 - 10 of 31
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv01061
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2022cv00639
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc. and Lupin Inc.
Counter Claimant:
Lupin Atlantis Holdings S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01408
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Supernus Pharmaceuticals, Inc. v. Lupin Limited et al
as 1:2021cv01293
Plaintiff:
Supernus Pharmaceuticals, Inc.
Defendant:
Lupin Limited, Lupin Atlantis Holdings S.A., Nanomi B.V. and others
Cause Of Action: 28 U.S.C. § 1338
Neurocrine Biosciences, Inc. v. Lupin Limited et al
as 1:2021cv01042
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Lupin Limited, Lupin Pharmaceuticals, Inc., Lupin Inc. and others
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2021cv00229
Defendant:
Lupin Pharmaceuticals, Inc., Lupin Limited, Lupin Atlantis Holdings, S.A. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Lupin Atlantis Holdings, S.A. et al
as 1:2020cv00415
Defendant:
Lupin Limited, Lupin Inc., Lupin Atlantis Holdings, S.A., Lupin Pharmaceuticals, Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al
as 1:2019cv01979
Defendant:
Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
PRIME EUROPEAN THERAPEUTICALS, S.P.A. v. NOVEL LABORATORIES, INC. et al
as 3:2017cv01944
Plaintiff:
PRIME EUROPEAN THERAPEUTICALS, S.P.A.
Defendant:
NOVEL LABORATORIES, INC. , GAVIS PHARMACEUTICALS, LLC , LUPIN ATLANTIS HOLDINGS, S.A. and others
Cause Of Action: 28 U.S.C. § 1338
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
